Please login to the form below

Not currently logged in
Email:
Password:

Increasing demand for online services from pharma

Study shows patients expect more help managing chronic conditions

US study shows patients increasingly expect online support from pharmaceutical companies to help manage their chronic conditions.

The results of the ePharma Consumer 2012 study by New York-based Manhattan Research represent a shift in public perception about the role of pharma companies, as long-term customer value becomes the norm.

The online research, which was conducted during Q4 2012 and involved 6,607 US adults, found 30 per cent of people with a chronic condition and 38 per cent of caregivers would register for a patient support programme.

Among the most popular features are:

  • Financial assistance
  • Meal plans and recipes
  • Tools to track/manage a condition
  • Registered nurse hotline.

The report also found that 75 per cent of people who use online patient support programmes from a pharma company said they felt confident the prescription they have is right for them because of support from the programme.

"Patients are interested in patient support programmes from pharma, and don't necessarily mind registering for access," said Monique Levy, vice president of Research at Manhattan Research.

"At the same time, pharma isn't top-of-mind as a destination, so marketers must consider partnering with other health resources such as general health websites, pharmacies and hospitals in an effort to gain traction for these programmes."

11th January 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
nitrogen

nitrogen is a strategic brand experience agency which blends science and imagination; delivering multi-channel communications that are both compelling and...

Latest intelligence

MORE MONEY FOR THE NHS – BUT IS THIS THE ANSWER?
Paul Mannu of Cello Health Insight says that politicians opening their pre-election cheque books can’t put the NHS where it needs to be – but pharma can play a major...
Medius Deal Watch
Pharma deals in February 2015
Pfizer and Valeant led the way during a respectable, if not record-breaking, month for mergers, acquisitions and collaborations...
Medius Deal Watch
Medius Deal Watch table for February 2015
The top major pharma mergers, acquisitions and collaborations during the month were led by the Pfizer/Hospira and Salix/Valeant deals...

Infographics